21 results
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants
8-K
EX-99.2
salg2hv8lg
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-99.1
9b4udmn
25 May 23
Regulation FD Disclosure
5:05pm
S-3
EX-1.2
40519p94vu9 s71gy
9 Nov 22
Shelf registration
4:15pm
8-K
EX-99.2
kbbwr 6bi6krmutwnc
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
10-K
1i233w5a e1
1 Mar 22
Annual report
4:07pm
10-Q
n2iqh0z6y9gxg8fc
2 Dec 21
Quarterly report
4:15pm
424B4
2ekqhbl
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
0qoskli yy0dd
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-1.1
kmkpa iolb
18 Oct 21
IPO registration (amended)
6:04am
S-1
925 ykvsk9u869x8yroc
1 Oct 21
IPO registration
4:49pm
DRS/A
3ch ychrglelwtrws1
14 Sep 21
Draft registration statement (amended)
12:00am